Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 11:13 PM
Ignite Modification Date:
2025-12-24 @ 11:13 PM
NCT ID:
NCT04650269
Eligibility Criteria:
Inclusion Criteria:
1. Adult (age\>18 years);
2. positive rapid HIV test;
3. ability to provide informed consent;
4. HIV RNA \> 200 copies/ml;
5. creatinine clearance \> 30 mg/dl as measured by serum creatinine;
6. no allergy to bictegravir/emtricitabine/tenofovir alafenamide (BFTAF) as indicated by patient history and self-reported allergies.
Exclusion Criteria:
1\) Any other comorbidities at the discretion of the investigator
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT04650269
Study Brief:
Protocol Section:
NCT04650269